Abstract

Vascular dementia, secondary to Alzheimer’s dementia, ranks as one of the most frequent dementia types. The process of vascular dementia is divergent with other neurodegenerative dementias and thus reversible at the early cognitive disorder or mild dementia stages. The encephalography and neuroimaging data mining at different stages would bring neuromodulation strategies in practice; 15 mild cognitive impairment patients and 16 mild vascular dementia patients as well as 17 cognitive healthy controls were screened in this study. Cognitive tests such as Mini-Mental State Examination, Montreal cognitive assessment, voxel-based morphometry, electroencephalography, and standardized low-resolution brain electromagnetic tomography connectivity network were conducted. Compared with healthy group, voxel-based morphometry analysis showed a decrease in gray/cerebrospinal fluid ratio ( p < .05) in mild dementia group; the energy power of gamma band decreased ( p < .05) in mild dementia group; and electroencephalography standardized low-resolution brain electromagnetic tomography analysis showed wider frontal and temporal lobe involvement in mild dementia patients ( p < .05). Network topological analysis screened top 10 key Brodmann areas (44R, 7R, 8L, 22L, 47L, 27L, 1L, 1R, 7R, 43L), which could be underlying neuromodulators for dementia patients. Electroencephalography as well as structural magnetic resonance imaging could be used for the evaluation of cognitive disorder patients. The spectrum-specific standardized low-resolution brain electromagnetic tomography analysis and connectivity network analysis could shed light on the neuromodulator targets in the early phase of dementia.

Highlights

  • No significant differences were found between progressive mild cognitive impairment (MCI) and stable MCI, but the largest difference in duration was found for microstate.[11]

  • Subjects were classified into MCI, mild dementia, and healthy control groups

  • Mild dementia and MCI groups presented lower Mini-Mental State Examination (MMSE) and Montreal cognitive assessment (MoCA) scores compared to healthy controls (p \ .05)

Read more

Summary

Introduction

EEG-based sLORETA analysis showed that Alpha-1 relative power current density in parietooccipital brain areas, Beta-1 in the frontal lobe, and delta relative power current density were found to be altered in vascular cognitive impairment, no dementia (VCIND) patients.[10] no significant differences were found between progressive MCI (pMCI) and stable MCI (sMCI), but the largest difference in duration was found for microstate.[11] the EEG method was used to test the treatment efficiency, and slow theta activity in parietal–occipital lobes was found in cognitive enhancer treatment of rats.[12]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call